Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Palrise LS 75mg/40mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Alarius Healthcare

Salt Composition

Levosulpiride (75mg) + Pantoprazole (40mg)

Overview Palrise LS 75mg/40mg Capsule SR

Gastroesophageal reflux disease (GERD), characterized by heartburn, stomach upset, and irritation, is treated with Palrise LS 75mg/40mg sustained-release capsules. This medication alleviates acidity symptoms, neutralizes stomach acid, and facilitates gas expulsion for improved comfort. Administered on an empty stomach, dosage and duration are determined by your physician based on individual needs and response. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Complete disclosure of all other medications to your healthcare provider is essential due to potential interactions. Common, generally transient side effects include abdominal pain, vomiting, diarrhea, headache, fever, nausea, rash, and flatulence. Report any concerns to your doctor immediately. Dizziness is a potential side effect; avoid driving or tasks demanding concentration until its impact is assessed. Alcohol consumption should be avoided due to potential dizziness exacerbation. Lifestyle changes, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, can enhance treatment efficacy. Prior to commencing treatment, inform your doctor of any kidney disease, pregnancy, pregnancy plans, or breastfeeding.

Uses of Palrise LS 75mg/40mg Capsule SR

Managing gastroesophageal reflux disease (GERD)

Major Benefits of Palrise LS 75mg/40mg Capsule SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire capsule without crushing, chewing, or breaking it. Administer Palrise LS 75mg/40mg SR Capsules on an empty stomach.

Common Side effects of Palrise LS 75mg/40mg Capsule SR:

  • Stomach pain
  • Vomiting
  • Diarrhea
  • Headache
  • Nausea
  • Flatulence
  • Fundic gland polyps
  • Fever
  • Skin rash
  • Dizziness

How to use Palrise LS 75mg/40mg Capsule SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Palrise LS 75mg/40mg Capsule SR whole; do not crush, chew, or break it. Administer on an empty stomach.

How Palrise LS 75mg/40mg Capsule SR works:

Each Palrise LS 75mg/40mg sustained-release capsule contains levosulpiride and pantoprazole, a dual-action medication.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Palrise LS 75mg/40mg sustained-release capsules and alcohol can result in heightened sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Palrise LS 75mg/40mg sustained-release capsules during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Palrise LS 75mg/40mg capsules are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Driving ability may be impaired by Palrise LS 75mg/40mg SR Capsules, which can induce drowsiness, dizziness, or dyskinesia. Patients should refrain from driving or operating machinery if experiencing these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should use Palrise LS 75mg/40mg sustained-release capsules cautiously. Dosage modification of Palrise LS 75mg/40mg sustained-release capsules may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should use Palrise LS 75mg/40mg sustained-release capsules cautiously. Dosage modification of Palrise LS 75mg/40mg sustained-release capsules may be necessary. Physician consultation is advised.

What if you forget to take Palrise LS 75mg/40mg Capsule SR :

Should you forget a dose of Palrise LS 75mg/40mg sustained-release capsules, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Palrise LS 75mg/40mg Capsule SR

LabelValue
Addictive None.
Medication Classification Stomach and intestinal

FAQs on Palrise LS 75mg/40mg Capsule SR

Administer Palrise LS 75mg/40mg sustained-release capsules precisely as prescribed by your physician. Optimal absorption is achieved by taking a single capsule each day on an empty stomach.
Individuals with hypersensitivity to any ingredient or inactive substance in Palrise LS 75mg/40mg sustained-release capsules should not take this medication.
Indeed, Palrise LS 75mg/40mg sustained-release capsules may induce dizziness, characterized by lightheadedness, weakness, unsteadiness, or faintness, in certain individuals. Should dizziness occur, it's advisable to rest until symptoms subside before resuming activities.
Research on Palrise LS 75mg/40mg Capsule SR in adult populations indicates a potential elevation in the incidence of osteoporosis-related fractures affecting the hip, wrist, or spine. This fracture risk appears heightened in individuals receiving higher dosages, which includes both multiple daily administrations and prolonged treatment exceeding one year.
Palrise LS 75mg/40mg Caps...
140
MRP 163
13% off